IL86731A0 - Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-2-carbonitrile derivatives - Google Patents

Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-2-carbonitrile derivatives

Info

Publication number
IL86731A0
IL86731A0 IL86731A IL8673188A IL86731A0 IL 86731 A0 IL86731 A0 IL 86731A0 IL 86731 A IL86731 A IL 86731A IL 8673188 A IL8673188 A IL 8673188A IL 86731 A0 IL86731 A0 IL 86731A0
Authority
IL
Israel
Prior art keywords
derivatives
estradien
androst
ene
pharmaceutical compositions
Prior art date
Application number
IL86731A
Other versions
IL86731A (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL86731A0 publication Critical patent/IL86731A0/en
Publication of IL86731A publication Critical patent/IL86731A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The medicine contains a progesterone synthesis inhibitor (ProH) of the trilostane or epostane type and an antigestagen (AG) and is used for inducing labour at term in humans and animals and for terminating normal or pathological pregnancy. The combination according to the invention is also suitable for treating hormone-dependent tumours, endometriosis and dysmenorrhoea.
IL86731A 1987-06-16 1988-06-14 Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-carbonitrile derivatives IL86731A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (en) 1987-06-16 1987-06-16 PROGESTERONE SYNTHESIS INHIBITOR AND ANTI-STAGE TO BEGINNING BIRTH OR FOR PREGNANCY

Publications (2)

Publication Number Publication Date
IL86731A0 true IL86731A0 (en) 1988-11-30
IL86731A IL86731A (en) 1992-11-15

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86731A IL86731A (en) 1987-06-16 1988-06-14 Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-carbonitrile derivatives

Country Status (12)

Country Link
EP (1) EP0296097B1 (en)
JP (1) JP2716461B2 (en)
AT (1) ATE94391T1 (en)
AU (1) AU611160B2 (en)
CA (1) CA1318251C (en)
DE (2) DE3720420A1 (en)
DK (1) DK327288A (en)
ES (1) ES2059556T3 (en)
IE (1) IE63453B1 (en)
IL (1) IL86731A (en)
PH (1) PH25728A (en)
ZA (1) ZA884315B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0667834T3 (en) * 1992-09-25 2000-10-30 Clive Barnes Prevention of formation of contaminant coatings in beer pipes
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
AU1775088A (en) 1988-12-22
ATE94391T1 (en) 1993-10-15
AU611160B2 (en) 1991-06-06
DE3884067D1 (en) 1993-10-21
DK327288A (en) 1988-12-17
IE63453B1 (en) 1995-04-19
DE3720420A1 (en) 1988-12-29
EP0296097B1 (en) 1993-09-15
IE881804L (en) 1988-12-16
CA1318251C (en) 1993-05-25
DK327288D0 (en) 1988-06-15
JPS63316725A (en) 1988-12-26
PH25728A (en) 1991-10-18
ZA884315B (en) 1989-06-28
EP0296097A2 (en) 1988-12-21
ES2059556T3 (en) 1994-11-16
IL86731A (en) 1992-11-15
JP2716461B2 (en) 1998-02-18
EP0296097A3 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
DK196691D0 (en) Steroid 5-alpha-reductase inhibitors
HU895286D0 (en) Process for the preparation of steroid 5alfa-reductase inhibiting compounds and pharmaceutical compositions containing such compounds
GB8826066D0 (en) New use of 11 28-dioxa-4-azatricyclo(22 3 1 0 4.9)octacos-18-ene derivatives & pharmaceutical compositions
DK502888D0 (en) USE OF AZITHROMYCINE AND DERIVATIVES THEREOF FOR THE PREPARATION OF ANTIPROTOZOAL MEDICINES
FR2558718B1 (en) DEVICE FOR THE PREPARATION AND POSITIONING OF "DIES" INTERESTING ALL OR PART OF ONE OR TWO DENTAL ARCADES ALLOWING EASY OCCLUSIVE OR ARTICULATOR
NZ222634A (en) Pyrrolidinylthio - substituted derivatives of azabicyclo(3.2.0)heptene carboxylic acids and pharmaceutical compositions thereof
GB2199747B (en) Fluticasone propionate compositions and their use in bowel diseases.
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
IL86731A0 (en) Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-2-carbonitrile derivatives
ES2016464A6 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives.
DK99987D0 (en) ESTROGEN PREPARATIONS
ES510546A0 (en) "PROCEDURE FOR PREPARING DERIVATIVES OF N- (N-METHYL-RN (N-AMINOSULFENYL DISUBSTITUTED) CARBAMOIL) OXI) S-METHYL THIOACETAMIDATE".
DE3168544D1 (en) 6,7,8,9-tetrahydro-3h-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives
NZ216246A (en) 2-azabicyclo(3.3.0 -7-octene-3-carboxylic acid derivatives and pharmaceutical compositions
NZ220242A (en) Regulating fertility in cattle by administering epostane
NZ189211A (en) 1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
DE3852245D1 (en) Derivatives of isoprene and anti-ulcer agents containing them.
DE3270466D1 (en) Pharmaceutical composition
FR2565098B1 (en) DEVICE FOR THE TREATMENT OF THERMAL LESIONS BY MEANS OF ABACTERIAL AIR

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees